Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma

Published:2019-09-12 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Enqvist Monika,Jacobs Benedikt,Junlén Henna R.,Schaffer Marie,Melén Christopher M.,Friberg Danielle,Wahlin Björn Engelbrekt,Malmberg Karl-Johan

Funder

Cancerfonden

Vetenskapsrådet

Barncancerfonden

Kreftforeningen

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Current therapeutic strategies and new treatment paradigms for follicular lymphoma;Kritharis;Cancer Treat Res.,2015

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med.,2002

3. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma;Maloney;J Clin Oncol.,1997

4. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol.,1998

5. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship;Dall'Ozzo;Cancer Res.,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset;Multiple Sclerosis and Related Disorders;2024-09

2. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells;International Journal of Molecular Sciences;2024-08-18

3. NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity;Biomedicines;2024-07-25

4. Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity;npj Precision Oncology;2024-05-20

5. T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCC;Blood;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3